Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience

Background: Randomized trials established topotecan and the combination of adriamycin, cyclophosphamide and vincristine (ACO) as second-line therapy options for small-cell lung cancer. We retrospectively evaluated the outcome of SCLC patients undergoing second-line chemotherapy. Patients and Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagmann, Raphael, Hess, Viviane, Zippelius, Alfred, Rothschild, Sacha I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615351/
https://www.ncbi.nlm.nih.gov/pubmed/26516363
http://dx.doi.org/10.7150/jca.13080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615351/
https://www.ncbi.nlm.nih.gov/pubmed/26516363
http://dx.doi.org/10.7150/jca.13080

Ejemplares similares